Bausch + Lomb Corporation (TSX:BLCO)

Market Cap	7.84B +41.3%
Revenue (ttm)	7.27B +7.8%
Net Income	-305.69M
EPS	-0.87
Shares Out	n/a
PE Ratio	n/a
Forward PE	16.63
Dividend	n/a
Ex-Dividend Date	n/a

Volume	600
Average Volume	2,246
Open	22.36
Previous Close	22.23
Day's Range	21.96 - 22.36
52-Week Range	15.21 - 25.70
Beta	0.59
RSI	51.38
Earnings Date	Apr 29, 2026

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during heali...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1853
• Employees: 13,000
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: BLCO

Financial Performance

In 2025, Bausch + Lomb's revenue was $5.10 billion, an increase of 6.47% compared to the previous year's $4.79 billion. Losses were -$360.00 million, 13.6% more than in 2024.

Financial numbers in USD